PDT director buys about 774 fund shares

John Hancock Dividend Fund director Kenneth J. Phelan reported purchasing common shares of the fund.

Rhea-AI Filing Summary

John Hancock Dividend Fund director Kenneth J. Phelan reported purchasing common shares of the fund. On January 26, 2026, he bought approximately 774.071 common shares of beneficial interest in the fund in an open-market transaction coded "P" at an approximate price of $12.92 per share.

After this transaction, he beneficially owned 774.071 common shares directly. The filing notes these figures are approximate because the fund’s net asset value, per-share price, and resulting share count cannot be precisely determined at the time of the filing.

Insider Trade Summary

Net Buyer: 774.071 shares

Net Buy 1 txn

Insider Phelan Kenneth J

Role Director

Bought 774.071 shs ($10K)

Type	Security	Shares	Price	Value
Purchase	Common Shares of Beneficial Interest	774.071	$12.92	$10K

Holdings After Transaction: Common Shares of Beneficial Interest — 774.071 shares (Direct)

Footnotes (1)

1. F1. This figure is approximate. Due to the timing of the Fund's determination of its net asset value, the price per share, and the number of shares of the Fund that corresponds to, or held as a result of, the purchase cannot be determined at the time of this filing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did PDT director Kenneth J. Phelan report?

Kenneth J. Phelan reported buying common shares of John Hancock Dividend Fund. On January 26, 2026, he acquired approximately 774.071 common shares of beneficial interest, increasing his directly held beneficial ownership to the same approximate amount after the transaction.

How many John Hancock Dividend Fund (PDT) shares did the director acquire?

The director acquired approximately 774.071 common shares of beneficial interest. This amount also represents his total beneficially owned shares following the transaction, according to the filing’s Table I summary of non-derivative securities beneficially owned after the reported purchase.

At what price did Kenneth J. Phelan buy his PDT shares?

The filing states an approximate purchase price of $12.92 per share. A footnote explains that, due to the timing of the fund’s net asset value determination, the exact price and corresponding number of shares cannot be precisely determined when the report was filed.

When did the reported PDT insider purchase by Phelan occur?

The purchase took place on January 26, 2026. This date is listed as the transaction date in Table I for the non-derivative securities, where the acquisition of approximately 774.071 common shares of beneficial interest is reported as a code "P" purchase.

Is Kenneth J. Phelan’s PDT ownership direct or indirect after this trade?

The filing shows his beneficial ownership as direct (D) after the transaction. Table I lists 774.071 common shares of beneficial interest beneficially owned following the trade, with the ownership form marked as direct, and no nature of indirect beneficial ownership indicated.

Why are the PDT share and price figures described as approximate?

The filing includes a footnote stating the figures are approximate. Because the fund’s net asset value and price per share are determined separately in time, the exact per-share price and corresponding number of shares from this purchase cannot be precisely determined at the filing time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/27/2026 - 04:42 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Phelan Kenneth J

(Last) (First) (Middle)

C/O JOHN HANCOCK

200 BERKELEY STREET

(Street)

BOSTON MA 02116

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
JOHN HANCOCK PREMIUM DIVIDEND FUND [ PDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares of Beneficial Interest(1)	01/26/2026		P		774.071(1)	A	$12.92(1)	774.071(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This figure is approximate. Due to the timing of the Fund's determination of its net asset value, the price per share, and the number of shares of the Fund that corresponds to, or held as a result of, the purchase cannot be determined at the time of this filing.

	Thomas W. Dee, by Power of Attorney	01/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.